Back

Transendocardial injection of autologous expanded CD34+ Stem Cells (ProtheraCytes) promotes reverse cardiac remodeling in patients with left ventricular dysfunction after acute myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials II Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

9 More presentations in this session

Presentation thumbnail
Discussant review - EXCELLENT
Professor F. Gustafsson (Pleasanton, US)
Slides Video
Presentation thumbnail
Bio-ADM as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure; data from STRONG-HF
Mr G. Voordes (Groningen, NL)
Slides Video
Presentation thumbnail
Discussant review - STRONG-HF
Professor A. Bayes Genis (Badalona, ES)
Slides Video
Presentation thumbnail
Semaglutide and cardiovascular outcomes in patients with overweight or obesity and heart failure: A pre-specified analysis from the SELECT trial
Professor J. Deanfield (London, GB)
Slides Video
Presentation thumbnail
Discussant review - SELECT
Professor P. Jhund (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials II
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources